Michael S. Poirier's Insider Trades & SAST Disclosures

Michael S. Poirier's most recent trade in Qualigen Therapeutics Inc was a trade of 375,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 11, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Qualigen Therapeutics Inc
Michael S. Poirier Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 375,000 375,000 - - Stock Option (Right to Buy)
Qualigen Therapeutics Inc
Michael S. Poirier Director, Chairman and CEO Purchase of securities on an exchange or from another person at price $ 0.57 per share. 22 Jun 2022 30,000 199,202 - 0.6 17,100 Common Stock
Qualigen Therapeutics Inc
Michael S. Poirier Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 1.80 per share. 20 Apr 2021 11,005 11,005 - 1.8 19,809 Common Stock
Qualigen Therapeutics Inc
Michael S. Poirier Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 1,000,000 1,000,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades